Stockreport

Omeros Presents New GPR174 Immuno-oncology Data Today at the American Association for Cancer Research Conference in Boston

Omeros Corporation  (OMER) 
Last omeros corporation earnings: 3/2 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.omeros.com
PDF -- GPR174 Deficiency Improves Outcomes in Animal Tumor Models -- SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced new findings on GPR174, i [Read more]